Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza

Background: Infectious respiratory pathogens like SARS-CoV-2 and influenza frequently mutate, leading to the emergence of variants. This necessitates continuous updates to FDA-approved vaccines with booster shots targeting the circulating variants. Vaccine hesitancy and needle injections create inco...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sharon Vijayanand, Smital Patil, Priyal Bagwe, Revanth Singh, Emmanuel Adediran, Martin J. D’Souza
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-03-01
Colecção:	Vaccines
Assuntos:	intranasal vaccine infectious diseases microparticles immunogenicity combination vaccine COVID-19
Acesso em linha:	https://www.mdpi.com/2076-393X/13/3/282
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!